Gerresheimer Begins Financial Year 2013 With Strong Revenue Growth
DÜSSELDORF, Germany, April 10, 2013 /PRNewswire/ --
- First-quarter revenues up 10.4% to EUR 296.7m
- Adjusted EBITDA margin reaches 15.5%
- Net income grows by 41.7% to EUR 10.2m
- Adjusted earnings per share increased to EUR 0.36
- Acquisition in India boosts activities in emerging markets
Gerresheimer AG, one of the leading global partners to the pharma and healthcare industry, increased revenues by 10.4% in the first quarter of the new, 2013 financial year. "The strong revenue growth in the first quarter largely relates to increased revenues in the Plastic Systems Division. The increase is mostly attributable to higher revenues from engineering services and tools paving the way for future business with drug delivery devices. Our latest acquisitions in India also contributed to the surge in revenues. There is furthermore healthy demand for pharma products overall," said Uwe Röhrhoff, CEO of Gerresheimer AG.
Gerresheimer increased revenues in the first quarter of financial year 2013 ( December 1, 2012 to November 30, 2013) by a substantial 10.4% to EUR 294.7m. The revenue increase was due primarily to strong organic growth in the Plastic Systems Division. This notably generated large revenues with tools and engineering services. There was also favorable demand for drug delivery devices such as insulin pens, asthma inhalers and prefillable glass syringes. Sound revenues were also attributable to primary pharma packaging such as glass injection vials, cartridges as well as plastic containers for solid and liquid medications. The two Indian companies acquired in 2012 - Triveni, a producer of plastic primary pharmaceutical packaging, and Neutral Glass, which produces glass pharmaceutical vials - also contributed to the marked revenue increase compared with the prior year.
The Gerresheimer Group generated adjusted EBITDA of EUR 46.0m in the first quarter of 2013, an increase of 2.1% on the prior-year quarter. The adjusted EBITDA margin was 15.5%, below the 16.8% margin in the comparative period. The main reason for the lower margin was the exceptionally strong revenue growth in engineering services and tools business in the Plastic Systems Division. While the tools business and engineering services have narrower margins, they are important in paving the way for the subsequent production of drug delivery devices. Net income after tax increased relative to the prior-year quarter by 41.7% to EUR 10.2m. Adjusted earnings per share rose by EUR 0.03 to EUR 0.36.Gerresheimer's capital expenditure in the first quarter of 2013 was EUR 16.6m, EUR 1.7m more than a year earlier. In December 2012, Gerresheimer also purchased 75% of shares in Triveni, the leading Indian producer of pharmaceutical plastic packaging and closures. Outlook
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV